National Academies Press: OpenBook

Issues in Risk Assessment (1993)

Chapter: DISCUSSION

« Previous: RESULTS
Suggested Citation:"DISCUSSION." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

regression line in Region B; the TD50 based on the data in the CPDB falls above the upper confidence limit on the regression line in Region A.

The TD50s in the CPDB for the 12 potential supercarcinogens already included in Krewski's 191 chemicals are generally very close to those calculated by Krewski. There are, however, two notable differences: EDB and vinyl chloride. The TD50 for EDB in the CPDB is based on lifetable methods, and is thus somewhat different than that calculated by Krewski using summary tumor incidence data. The discrepency between the Gold and Krewski TD50s for vinyl chloride based on the data from the CPDB is apparently due to differences in the numerical procedures used in model fitting. (This difference is small in relation to the wide variation in TD50s in the CPDB based on different experiments with vinyl chloride.) Neither of these differences is particularly relevant to the search for supercarcinogens because the TD50s for these two compounds do not fall in Region C.

DISCUSSION

The results just discussed do not provide strong evidence of the existence of supercarcinogens. Of the 14 chemicals considered as potential supercarcinogens, only five fall inside Region C; even these five are only slightly beyond the boundary separating regions B and C.

These results are based on certain assumptions about the appropriate adjustments to be applied to dose (and hence to potency) in experiments that are terminated substantially earlier than the 2 year lifetime of rodents. Those assumptions are based on sparse empirical evidence and are somewhat arbitrary. A common generalization is that cancer incidence is proportional to fn where the exponent n may range from 2 to 6 (Armitage and Doll, 1961). The CPDB's procedures are equivalent to the assumption that n = 2, which gives relatively low estimates of carcinogenic potency. An assumption that n = 3 or higher would shift the estimates of TD50 for the chemicals under review still further into Region C.

In summary, the results of the committee's informal study suggest that supercarcinogens are rare. The best candidates for designation as supercarcinogens are a few agents that induce cancer in rodents unusually

Suggested Citation:"DISCUSSION." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

early in life. For such agents, the definition of potency is somewhat arbitrary: the more account that is taken of their early action, the higher the estimates of potency and the weaker the general relationship between potency and toxicity.

Suggested Citation:"DISCUSSION." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
This page in the original is blank.
Suggested Citation:"DISCUSSION." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 182
Suggested Citation:"DISCUSSION." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 183
Suggested Citation:"DISCUSSION." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 184
Next: Issues in Risk Assessment The Two-Stage Model Of Carcinogenesis »
Issues in Risk Assessment Get This Book
×
Buy Paperback | $65.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The scientific basis, inference assumptions, regulatory uses, and research needs in risk assessment are considered in this two-part volume.

The first part, Use of Maximum Tolerated Dose in Animal Bioassays for Carcinogenicity, focuses on whether the maximum tolerated dose should continue to be used in carcinogenesis bioassays. The committee considers several options for modifying current bioassay procedures.

The second part, Two-Stage Models of Carcinogenesis, stems from efforts to identify improved means of cancer risk assessment that have resulted in the development of a mathematical dose-response model based on a paradigm for the biologic phenomena thought to be associated with carcinogenesis.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!